FDA approves ViaCyte's stem cell trial for type 1 diabetes

08/22/2014 | San Diego Union-Tribune

The FDA has cleared the way for ViaCyte's application to start a Phase I/II clinical trial of VC-01 for the treatment of type 1 diabetes. Insulin-producing cells derived from stem cells will be implanted inside a semi-permeable pouch. The trial is funded by the California Institute for Regenerative Medicine.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations